Concepedia
Statistics
Publications
56
Citations
2.7K
H-Index
29
Active since
1969
Affiliations
University of Iowa(Current)
Gilead Sciences (United States)
Sarah Cannon
Cornell University
Washington University in St. Louis
David M. Johnson is an author at University of Iowa specializing in pharmacology, antibiotic resistance, and medicine.
Publications per year
1969–2024
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
Susan O’Brien, Nicole Lamanna, Thomas J. Kipps et al. · Blood · 2015 · 240 citations · Full text
Pharmacy, Immunology, Pharmacotherapy +9
Localization of position within a homogeneous behavior chain: Effects of error contingencies
John R. Platt, David M. Johnson · Learning and Motivation · 1971 · 220 citations
Public Health, Behavioral Sciences, Psychology +10
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
Ian W. Flinn, Brad S. Kahl, John P. Leonard et al. · Blood · 2014 · 209 citations · Full text
Medicine, Oncology, Pharmacology +11
In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones
Ronald N. Jones, David M. Johnson, M E Erwin · Antimicrobial Agents and Chemotherapy · 1996 · 127 citations · Full text
Life Sciences, Microbiology, Pharmacology +14
Progression and Recapitulation of the Chondrocyte Differentiation Program: Cartilage Matrix Protein Is a Marker for Cartilage Maturation
Qian Chen, David M. Johnson, Dominik R. Haudenschild et al. · Developmental Biology · 1995 · 118 citations
Life Sciences, Cell Biology, Developmental Biology +14
1–5 of 56